Inhaltsbereich
| 20 Einträge |
Seite 1 / 1
 Druckansicht
|
| The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon. |
| Aggarwal A, Prinz-Wohlgenannt M, Gröschel C, Tennakoon S, Meshcheryakova A, Chang W, Brown EM, Mechtcheriakova D, Kállay E |
| Molecular cancer. 2015 Mar 18. doi: 10.1186/s12943-015-0330-4. pii: 10.1186/s12943-015-0330-4. pmc: PMC4405849 |
| PMID: 25879211 |
| LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. |
| Aschacher T, Wolf B, Enzmann F, Kienzl P, Messner B, Sampl S, Svoboda M, Mechtcheriakova D, Holzmann K, Bergmann M |
| Oncogene. 2015 Mar 23. pii: onc201565. doi: 10.1038/onc.2015.65 |
| PMID: 25798839 |
| B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. |
| Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D, Stremitzer S, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D |
| PloS one. 2014 Jun 6. doi: 10.1371/journal.pone.0099008. pii: PONE-D-14-04301. pmc: PMC4048213 |
| PMID: 24905750 |
| Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients. |
| Singer J, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Willmann M, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E |
| Molecular cancer therapeutics. 2014 Apr 22. pii: 1535-7163.MCT-13-0288. doi: 10.1158/1535-7163.MCT-13-0288. pmc: PMC4174294. mid: EMS60298 |
| PMID: 24755200 |
| Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R. |
| Mirkina I, Hadzijusufovic E, Krepler C, Mikula M, Mechtcheriakova D, Strommer S, Stella A, Jensen-Jarolim E, Höller C, Wacheck V, Pehamberger H, Valent P |
| PloS one. 2014 Jan 29. doi: 10.1371/journal.pone.0084417. pii: PONE-D-13-39207. pmc: PMC3906015 |
| PMID: 24489649 |
| Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer. |
| Mechtcheriakova D, Svoboda M, Meshcheryakova A, Jensen-Jarolim E |
| Cancer immunology, immunotherapy : CII. 2012 Apr 19. doi: 10.1007/s00262-012-1255-z. pmc: PMC3427704. mid: UKMS48526 |
| PMID: 22527246 |
| Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting. |
| Singer J, Weichselbaumer M, Stockner T, Mechtcheriakova D, Sobanov Y, Bajna E, Wrba F, Horvat R, Thalhammer JG, Willmann M, Jensen-Jarolim E |
| Molecular immunology. 2012 Mar 19. pii: S0161-5890(12)00003-X. doi: 10.1016/j.molimm.2012.01.002. pmc: PMC3318186 |
| PMID: 22424313 |
| Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. |
| Lucerna M, Pomyje J, Mechtcheriakova D, Kadl A, Gruber F, Bilban M, Sobanov Y, Schabbauer G, Breuss J, Wagner O, Bischoff M, Clauss M, Binder BR, Hofer E |
| Cancer research. 2006 Jul 4. pii: 66/13/6708. doi: 10.1158/0008-5472.CAN-05-2732. pmc: PMC2882226. mid: UKMS30448 |
| PMID: 16818645 |
| Quantitative proteomics reveals protein kinases and phosphatases in the individual phases of contextual fear conditioning in the C57BL/6J mouse. |
| Šmidák R, Mayer R, Bileck A, Gerner C, Mechtcheriakova D, Stork O, Lubec G, Li L |
| Behavioural brain research. 2015 Dec 31. pii: S0166-4328(15)30342-9. doi: 10.1016/j.bbr.2015.12.033 |
| PMID: 26748257 |
| Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach. |
| Meshcheryakova A, Svoboda M, Tahir A, Köfeler HC, Triebl A, Mungenast F, Heinze G, Gerner C, Zimmermann P, Jaritz M, Mechtcheriakova D |
| Oncotarget. 2016 Mar 7. pii: 7947. doi: 10.18632/oncotarget.7947 |
| PMID: 26967245 |
| AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer. |
| Svoboda M, Meshcheryakova A, Heinze G, Jaritz M, Pils D, Castillo-Tong DC, Hager G, Thalhammer T, Jensen-Jarolim E, Birner P, Braicu I, Sehouli J, Lambrechts S, Vergote I, Mahner S, Zimmermann P, Zeillinger R, Mechtcheriakova D |
| BMC genomics. 2016 Aug 16. doi: 10.1186/s12864-016-3001-y. pii: 10.1186/s12864-016-3001-y |
| PMID: 27527602 |
| AllergoOncology - The impact of Allergy in Oncology. EAACI Position Paper. |
| Jensen-Jarolim E, Bax HJ, Bianchini R, Capron M, Corrigan C, Castells M, Dombrowicz D, Daniels-Wells TR, Fazekas J, Fiebiger E, Gatault S, Gould HJ, Janda J, Josephs DH, Karagiannis P, Levi-Schaffer F, Meshcheryakova A, Mechtcheriakova D, Mekori Y, Mungenast F, Nigro EA, Penichet ML, Redegeld F, Saul L, Singer J, Spicer JF, Siccardi AG, Spillner E, Turner MC, Untersmayr E, Vangelista L, Karagiannis SN |
| Allergy. 2016 Dec 29. doi: 10.1111/all.13119 |
| PMID: 28032353 |
| Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R. |
| Pfanzagl B, Mechtcheriakova D, Meshcheryakova A, Aberle SW, Pfragner R, Jensen-Jarolim E |
| Scientific reports. 2017 May 2. doi: 10.1038/s41598-017-01453-5. pii: 10.1038/s41598-017-01453-5. pmc: PMC5430954 |
| PMID: 28465562 |
| Reduced Levels of the Synaptic Functional Regulator FMRP in Dentate Gyrus of the Aging Sprague-Dawley Rat. |
| Smidak R, Sialana FJ, Kristofova M, Stojanovic T, Rajcic D, Malikovic J, Feyissa DD, Korz V, Hoeger H, Wackerlig J, Mechtcheriakova D, Lubec G |
| Frontiers in aging neuroscience. 2017 Nov 23. doi: 10.3389/fnagi.2017.00384. pmc: PMC5703695 |
| PMID: 29218006 |
| Resveratrol Inhibits Key Steps of Steroid Metabolism in a Human Estrogen-Receptor Positive Breast Cancer Model: Impact on Cellular Proliferation. |
| Poschner S, Maier-Salamon A, Zehl M, Wackerlig J, Dobusch D, Meshcheryakova A, Mechtcheriakova D, Thalhammer T, Pachmann B, Jäger W |
| Frontiers in pharmacology. 2018 Jul 10. doi: 10.3389/fphar.2018.00742. pmc: PMC6048268 |
| PMID: 30042681 |
| Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer. |
| Svoboda M, Mungenast F, Gleiss A, Vergote I, Vanderstichele A, Sehouli J, Braicu E, Mahner S, Jäger W, Mechtcheriakova D, Cacsire-Tong D, Zeillinger R, Thalhammer T, Pils D |
| Frontiers in pharmacology. 2018 Aug 7. doi: 10.3389/fphar.2018.00842. pmc: PMC6090214 |
| PMID: 30131693 |
| Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer. |
| Meshcheryakova A, Svoboda M, Jaritz M, Mungenast F, Salzmann M, Pils D, Cacsire Castillo-Tong D, Hager G, Wolf A, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Birner P, Zimmermann P, Brindley DN, Heinze G, Zeillinger R, Mechtcheriakova D |
| Computational and structural biotechnology journal. 2019 Apr 10. doi: 10.1016/j.csbj.2019.04.004. pii: S2001-0370(18)30265-4. pmc: PMC6479272 |
| PMID: 31049165 |
| Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells. |
| Poschner S, Wackerlig J, Castillo-Tong DC, Wolf A, Decken IV, Rižner TL, Pavlič R, Meshcheryakova A, Mechtcheriakova D, Fritzer-Szekeres M, Thalhammer T, Jäger W |
| Cancers. 2020 Jan 23. pii: cancers12020279. doi: 10.3390/cancers12020279 |
| PMID: 31979221 |
| Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer. |
| Buxhofer-Ausch V, Német O, Sheikh M, Andrikovics H, Reiner A, Ausch C, Mechtcheriakova D, Tordai A, Gleiss A, Özvegy-Laczka C, Jäger W, Thalhammer T |
| Oncology letters. 2020 Sep 17. doi: 10.3892/ol.2020.12115. pii: OL-0-0-12115. pmc: PMC7509609 |
| PMID: 32994815 |
| The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer. |
| Mungenast F, Meshcheryakova A, Beer A, Salzmann M, Tamandl D, Gruenberger T, Pietschmann P, Koperek O, Birner P, Kirsch I, Robins H, Mittlboeck M, Jaritz M, Bergmann M, Zimmermann P, Mechtcheriakova D |
| Cancers. 2020 Oct 25. pii: cancers12113117. doi: 10.3390/cancers12113117 |
| PMID: 33113874 |
| 20 Einträge |
Seite 1 / 1
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
